within Pharmacolibrary.Drugs.ATC.N;

model N02CC02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.74,
    Cl             = 0.00011833333333333333,
    adminDuration  = 600,
    adminMass      = 2.5 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.17,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0021666666666666666,
    Tlag           = 10.200000000000001
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N02CC02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Naratriptan is a selective serotonin 5-HT1B/1D receptor agonist used for the acute treatment of migraine attacks with or without aura in adults. It is approved for use in several countries and is available as oral tablets.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers following single oral dose administration.</p><h4>References</h4><ol><li><p>Tfelt-Hansen, P (2021). Naratriptan is as effective as sumatriptan for the treatment of migraine attacks when used properly. A mini-review. <i>Cephalalgia : an international journal of headache</i> 41(14) 1499–1505. DOI:<a href=\"https://doi.org/10.1177/03331024211028959\">10.1177/03331024211028959</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/34275352/\">https://pubmed.ncbi.nlm.nih.gov/34275352</a></p></li><li><p>Christensen, ML, et al., &amp; Hak, LJ (2001). Pharmacokinetics of naratriptan in adolescent subjects with a history of migraine. <i>Journal of clinical pharmacology</i> 41(2) 170–175. DOI:<a href=\"https://doi.org/10.1177/00912700122009980\">10.1177/00912700122009980</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/11210397/\">https://pubmed.ncbi.nlm.nih.gov/11210397</a></p></li><li><p>Tfelt-Hansen, P (2007). Parenteral vs. oral sumatriptan and naratriptan: plasma levels and efficacy in migraine. a comment. <i>The journal of headache and pain</i> 8(5) 273–276. DOI:<a href=\"https://doi.org/10.1007/s10194-007-0411-x\">10.1007/s10194-007-0411-x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/17955173/\">https://pubmed.ncbi.nlm.nih.gov/17955173</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N02CC02;
